Tenofovir Alafenamide Tablets: Clinical Trials

3 trials of Tenofovir Alafenamide Tablets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 2 Phase 4, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 1, Unknown 1
Phase 21Completed 1

Follow Tenofovir Alafenamide Tablets: new trials by email Literature Review of Tenofovir Alafenamide Tablets trials Research Report on Tenofovir Alafenamide Tablets

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients
Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets - Chronic Hepatitis B
Phase 2CompletedShanghai HEP Pharmaceutical Co., Ltd.82022-08-232024-07-15
Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women
Tenofovir Alafenamide Tablets - Chronic Hepatitis b, Tenofovir Alafenamide Fumarate
Phase 4RecruitingFirst People's Hospital of Hangzhou502021-05-062025-09-08
Tenofovir Alafenamide in HBV Related Decompensated Liver
Tenofovir Alafenamide Tablets - HBV
Phase 4UnknownKaohsiung Medical University Chung-Ho Memorial Hospital1002020-09-012020-12-24

Conditions studied

Hepatitis B, Chronic (2)

Sponsors

First People's Hospital of Hangzhou (1)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (1)  ·  Shanghai HEP Pharmaceutical Co., Ltd. (1)

Countries

China (2)  ·  Taiwan (1)

Top investigators

Ming-Lung Yu, Professor (1)  ·  Qin Zhang (1)  ·  Siying Li, MD (1)  ·  Zhiyuan Ma, PhD (1)